Divi’s Laboratories Q4 results: Divi’s Laboratories on Saturday, May 25 announced January-March quarter results for the financial year 2023-24 (Q4FY24), reporting 67.6% rise in net profit to ₹538 crore. Whereas last year it was ₹321 Crore. Same period last year.
The pharma major’s revenue from operations grew 18% to ₹2,303 Crore in Q4FY24, compared to ₹1,951 Crore in the year-ago period. The company’s board also declared a dividend of ₹2 (at 1,500 per cent) per equity share at face value of ₹30 for the financial year ending March 31, 2024.
